Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 3 Issue 2, February 2023

Mitochondria in the spotlight

In this issue, Berry and colleagues use an optogenetics approach to oppose the age-associated decline in the membrane potential of mitochondria with a light-activated proton pump, and show that it increases both the healthspan and lifespan of worms. The issue cover evokes the experimental paradigm used in the study with light being shone onto a mitochondrion, placing the organelle in the spotlight.

See Berry et al.

Cover image: Sciepro/Science Photo Library/Getty. Cover Design: Lauren Heslop

Comment & Opinion

  • There is tremendous interest in the development of drugs that target senescent cells (‘senolytic’ drugs) to treat a range of age-related morbidities. However, studies in mice that demonstrate impaired tissue repair following clearance of senescent cells raise questions about the potential risks of senolytic therapies. Closer examination of the available studies reveals the hopeful possibility of a ‘therapeutic window’ in which these risks can be minimized.

    • Sundeep Khosla
    Comment

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • Zhang and colleagues demonstrate how the premature aging phenotypes in progeria involve a mitotic spindle-assembly-checkpoint protein, BUBR1. BUBR1 is misanchored to the nuclear membrane by progerin and its mRNA is destabilized in progeria, preventing it from functioning properly.

    • Huijing Xue
    • Kan Cao
    News & Views
  • Aging is known to be associated with a decline in memory and mood, but the molecular mechanisms that underlie these changes remain unclear. Moigneu, Abdellaoui and colleagues show that growth differentiation factor 11 reverses deficits in these functions in aged mice, pointing the way towards a novel pro-mnemonic and antidepressant therapeutic target.

    • Patrick T. Piantadosi
    • Andrew Holmes
    News & Views
Top of page ⤴

Research Briefings

  • Mitochondrial dysfunction is central in biological aging, but experimentally controlling mitochondria in vivo to test causality has been difficult. Optogenetically preserving mitochondrial function with age addressed this difficulty and increased lifespan and healthspan in Caenorhabditis elegans.

    Research Briefing
  • Age-related decline in brain health is associated with poor blood flow and limitations in energy supply, although the vascular mechanisms are poorly understood. We report an age-related decrease in responsivity of brain microvessels, accompanied by a decrease in vessel density and loss of vascular mural cell processes.

    Research Briefing
  • Neuroinflammation is increasingly recognized as an important pathological trigger for the development and progression of Alzheimer’s disease. However, the molecular mechanism remains largely unclear. We identify activation of the neuroimmune cGAS–STING signaling pathway as a critical molecular link, predominantly in microglia, that contributes to Alzheimer’s disease pathogenesis.

    Research Briefing
Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links